Clinical Trials Browser

Phase 2 × Interventional × Inflammatory Bowel Diseases × Clear all

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT01714726 2021-05-26

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Phase 2 Completed

121 enrolled 22 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT02574637 2021-05-26

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Phase 2 Terminated

29 enrolled 25 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT02426762 2015-08-13

Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery

Phase 2 Unknown

GastrointestinalSarcoma

Diverticulum, Stomach Neoplasms, Surgical Wound Infection, Colorectal Neoplasms, Inflammatory Bowel Diseases, Gastrointestinal Stromal Tumors

NCT01155440 2011-11-28

Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases